Literature DB >> 7910172

Processing of urushiol (poison ivy) hapten by both endogenous and exogenous pathways for presentation to T cells in vitro.

R S Kalish1, J A Wood, A LaPorte.   

Abstract

The antigen processing requirements for urushiol, the immunogen of poison ivy (Toxicodendron radicans), were tested by presentation of urushiol to cultured human urushiol-responsive T cells. Urushiol was added to antigen-presenting cells (APC) either before or after fixation with paraformaldehyde. Three distinct routes of antigen processing were detected. CD8+ and CD4+ T cells, which were dependent upon processing, proliferated if urushiol was added to APC before fixation, but did not proliferate when urushiol was added to APC after fixation. Processing of urushiol for presentation to CD8+ T cells was inhibited by azide, monensin, and brefeldin A. This suggests that urushiol was processed by the endogenous pathway. In contrast, presentation of urushiol to CD4+ T cells was inhibited by monensin but not by brefeldin A. This was compatible with antigen processing by the endosomal (exogenous) pathway. Finally, certain CD8+ T cells recognized urushiol in the absence of processing. These cells proliferated in response to APC incubated with urushiol after fixation. Classification of contact allergens by antigen processing pathway may predict the relative roles of CD4+ and CD8+ cells in the immunopathogensis of allergic contact dermatitis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7910172      PMCID: PMC294319          DOI: 10.1172/JCI117198

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  47 in total

1.  Synthetic peptides anchor T cell-specific TNP epitopes to MHC antigens.

Authors:  B Ortmann; S Martin; A von Bonin; E Schiltz; H Hoschützky; H U Weltzien
Journal:  J Immunol       Date:  1992-03-01       Impact factor: 5.422

2.  Role of hapten-anchoring peptides in defining hapten-epitopes for MHC-restricted cytotoxic T cells. Cross-reactive TNP-determinants on different peptides.

Authors:  S Martin; B Ortmann; U Pflugfelder; U Birsner; H U Weltzien
Journal:  J Immunol       Date:  1992-10-15       Impact factor: 5.422

3.  Ham-2 corrects the class I antigen-processing defect in RMA-S cells.

Authors:  M Attaya; S Jameson; C K Martinez; E Hermel; C Aldrich; J Forman; K F Lindahl; M J Bevan; J J Monaco
Journal:  Nature       Date:  1992-02-13       Impact factor: 49.962

4.  The class II MHC-restricted presentation of endogenously synthesized ovalbumin displays clonal variation, requires endosomal/lysosomal processing, and is up-regulated by heat shock.

Authors:  M T Michalek; B Benacerraf; K L Rock
Journal:  J Immunol       Date:  1992-02-15       Impact factor: 5.422

5.  Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents.

Authors:  S Ohkuma; B Poole
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

6.  Processing requirements for T cell activation by Mycoplasma arthritidis-derived mitogen.

Authors:  A Bauer; I Rutenfranz; H Kirchner
Journal:  Eur J Immunol       Date:  1988-12       Impact factor: 5.532

7.  Predominance of epidermal CD8+ T lymphocytes in bullous cutaneous reactions caused by beta-lactam antibiotics.

Authors:  M Hertl; H Bohlen; F Jugert; C Boecker; R Knaup; H F Merk
Journal:  J Invest Dermatol       Date:  1993-12       Impact factor: 8.551

8.  Antigen presentation requires transport of MHC class I molecules from the endoplasmic reticulum.

Authors:  J H Cox; J W Yewdell; L C Eisenlohr; P R Johnson; J R Bennink
Journal:  Science       Date:  1990-02-09       Impact factor: 47.728

9.  Evidence for an arene oxide-NIH shift pathway in the metabolic conversion of phenytoin to 5-(4-hydroxyphenyl)-5-phenylhydantoin in the rat and in man.

Authors:  M Claesen; M A Moustafa; J Adline; D Vandervorst; J H Poupaert
Journal:  Drug Metab Dispos       Date:  1982 Nov-Dec       Impact factor: 3.922

10.  Quantitation and cloning of human urushiol specific peripheral blood T-cells: isolation of urushiol triggered suppressor T-cells.

Authors:  R S Kalish; C Morimoto
Journal:  J Invest Dermatol       Date:  1989-01       Impact factor: 8.551

View more
  7 in total

1.  Polymerized urushiol of the commercially available rhus product in Korea.

Authors:  Seung Hyun Cheong; You Won Choi; Byung Sun Min; Hae Young Choi
Journal:  Ann Dermatol       Date:  2010-02-28       Impact factor: 1.444

2.  Cracking the code of skin inflammation with CD1a.

Authors:  Masayuki Amagai
Journal:  Nat Immunol       Date:  2016-09-20       Impact factor: 25.606

Review 3.  [Basis for the treatment of eczematous diseases in otorhinolaryngology].

Authors:  R Fölster-Holst; A Sperl; T Albrecht; L Klimek
Journal:  HNO       Date:  2017-10       Impact factor: 1.284

4.  Clinical Features of Systemic Contact Dermatitis Due to the Ingestion of Lacquer in the Province of Chungcheongnam-do.

Authors:  Jung Eun Kim; Sung Yul Lee; Jong Suk Lee; Young Lip Park; Kyu Uang Whang
Journal:  Ann Dermatol       Date:  2012-07-25       Impact factor: 1.444

5.  Elevated levels of antibodies against xenobiotics in a subgroup of healthy subjects.

Authors:  Aristo Vojdani; Datis Kharrazian; Partha Sarathi Mukherjee
Journal:  J Appl Toxicol       Date:  2014-07-18       Impact factor: 3.446

6.  Lithraea caustic (Litre) Extract Promotes an Antitumor Response Against B16 Melanoma.

Authors:  Claudia Robles-Planells; Sofia A Michelson; Javier Mena; Daniela Escrig; Juan L Rojas; Giselle Sanchez-Guerrero; Ronny Hernández; Carlos Barrera-Avalos; Leonel E Rojo; Daniela Sauma; Alexis M Kalergis; Mónica Imarai; Ricardo Fernández; Carolina A Robles; Elías Leiva-Salcedo; Rocio Santander; Alejandro Escobar; Claudio Acuña-Castillo
Journal:  Front Pharmacol       Date:  2019-10-22       Impact factor: 5.810

7.  CD1a on Langerhans cells controls inflammatory skin disease.

Authors:  Ji Hyung Kim; Yu Hu; Tang Yongqing; Jessica Kim; Victoria A Hughes; Jérôme Le Nours; Elsa A Marquez; Anthony W Purcell; Qi Wan; Masahiko Sugita; Jamie Rossjohn; Florian Winau
Journal:  Nat Immunol       Date:  2016-08-22       Impact factor: 25.606

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.